Genscript Biotech Corporation (HKG:1548)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
12.20
-0.06 (-0.49%)
Apr 3, 2025, 4:08 PM HKT

Genscript Biotech Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020 2015 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
2,962-95.48-226.85-358.71-204.95
Upgrade
Depreciation & Amortization
69.1271.8561.1845.8632.33
Upgrade
Other Amortization
-2.193.071.920.56
Upgrade
Loss (Gain) From Sale of Assets
-0.690.770.911.11
Upgrade
Asset Writedown & Restructuring Costs
-11.6611.48-3.56
Upgrade
Loss (Gain) From Sale of Investments
--2.433.64-0.53-1.8
Upgrade
Loss (Gain) on Equity Investments
-1.380.03-0.6
Upgrade
Stock-Based Compensation
-60.5965.1539.6917.64
Upgrade
Provision & Write-off of Bad Debts
-4.781.150.93-0.64
Upgrade
Other Operating Activities
-2,955-255.25-204.38-9.5116.98
Upgrade
Change in Accounts Receivable
--116.9938.071.57-69.91
Upgrade
Change in Inventory
--3.93-19.53-15.14-14.97
Upgrade
Change in Accounts Payable
--37.0325.588.075.43
Upgrade
Change in Unearned Revenue
-100.776.763.5431.48
Upgrade
Change in Other Net Operating Assets
--29.74113.59144.631.49
Upgrade
Operating Cash Flow
75.65-286.91-120.29-136.79-151.09
Upgrade
Capital Expenditures
-197-252.45-216.11-133.04-121.88
Upgrade
Sale of Property, Plant & Equipment
-0.240.090.270.06
Upgrade
Sale (Purchase) of Intangibles
--4.05-2.27-4.35-5.87
Upgrade
Investment in Securities
-448.2-101.72-219.75-82.4426.49
Upgrade
Other Investing Activities
-811.160.25-5.257.021.04
Upgrade
Investing Cash Flow
-1,456-357.73-443.3-212.55-100.17
Upgrade
Long-Term Debt Issued
44.474.3933.0626.0452.92
Upgrade
Total Debt Issued
44.474.3933.0626.0452.92
Upgrade
Long-Term Debt Repaid
-9.6-34.06-7.39-74.94-30.6
Upgrade
Total Debt Repaid
-9.6-34.06-7.39-74.94-30.6
Upgrade
Net Debt Issued (Repaid)
34.840.3325.67-48.8922.33
Upgrade
Issuance of Common Stock
13.517.65228.13951.23459.56
Upgrade
Repurchase of Common Stock
-----9.46
Upgrade
Other Financing Activities
18.221,010165.52-0.19-8.67
Upgrade
Financing Cash Flow
66.521,068419.32902.14624.2
Upgrade
Foreign Exchange Rate Adjustments
-0.22-1.22-12.7-0.893.72
Upgrade
Net Cash Flow
-1,314422.4-156.97551.91376.66
Upgrade
Free Cash Flow
-121.35-539.36-336.41-269.83-272.97
Upgrade
Free Cash Flow Margin
-20.41%-64.24%-53.76%-55.06%-69.84%
Upgrade
Free Cash Flow Per Share
-0.06-0.26-0.16-0.13-0.14
Upgrade
Cash Interest Paid
-3.192.041.581.33
Upgrade
Cash Income Tax Paid
-2.66-0.660.71-4.53
Upgrade
Levered Free Cash Flow
-113.67-594.79-342.98-176.43-224.26
Upgrade
Unlevered Free Cash Flow
-108.65-577.6-334.69-174.95-223.37
Upgrade
Change in Net Working Capital
6.81195.87-28.03-112.0418.32
Upgrade
Updated Mar 12, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.